Avantis International Small Cap Value ETF vs Centene Corp — how do they compare? Avantis International Small Cap Value ETF trades at $105.24, while Centene Corp trades at $66.09 (market cap $33.93B). The key difference: Centene Corp is trading nearer its 52-week high, Avantis International Small Cap Value ETF nearer its low. Which is the better fit depends on your goals.
| AVDV | CNC | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $110.40 | $68.72 |
52-Week Low | $80.02 | $25.21 |
Market Cap | — | $33.93B |
Enterprise Value | — | $26.56B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
Trailing returns across standard periods
Latest headlines on both assets
AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.
Read more on AVDV →Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →